Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Diet  COVID-19 treatment studies for Diet  C19 studies: Diet  Diet   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Case 92% Improvement Relative Risk c19early.org/dt Moludi et al. Diet for COVID-19 Prophylaxis Is a healthy diet beneficial for COVID-19? Retrospective study in Iran (June - July 2020) Fewer cases with healthier diets (p<0.000001) Moludi et al., British J. Nutrition, doi:10.1017/S0007114521003214 Favors healthy diet Favors control
The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case–control study of COVID-19 patients
Moludi et al., British Journal of Nutrition, doi:10.1017/S0007114521003214
Moludi et al., The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a.., British Journal of Nutrition, doi:10.1017/S0007114521003214
Aug 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 60 COVID-19 hospitalized patients and 60 controls in Iran, showing pro-inflammatory diets associated with COVID-19 cases and severity. IR.KUMS.REC.1399·444, IR.TBZMED.REC.1399·225.
risk of case, 91.6% lower, OR 0.08, p < 0.001, inverted to make OR<1 favor higher quality diet, case control OR, model 3, E-DII tertile 1 vs. tertile 3.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Moludi et al., 23 Aug 2021, retrospective, Iran, peer-reviewed, 7 authors, study period June 2020 - July 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperDietAll
Abstract: British Journal of Nutrition, page 1 of 9 © The Author(s), 2021. Published by Cambridge University Press on behalf of The Nutrition Society doi:10.1017/S0007114521003214 The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case–control study of COVID-19 patients Jalal Moludi1,2,3, Shaimaa A. Qaisar4, Mohammad Alizadeh5*, Hamed Jafari Vayghan6, Mohammad Naemi5, Akram Rahimi3 and Rihaneh Mousavi5 1 Department of Nutritional Sciences, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran 2 Research Center for Environmental Determinants of Health (RCEDH), Kermanshah University of Medical Sciences, Kermanshah, Iran 3 Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran 4 Chemistry Department, College of Education, University of Garmian, Sulimmania, Iraq 5 Nutrition Research Center, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran 6 Department of Nutrition, School of Health, Arak University of Medical Sciences, Arak, Iran (Submitted 9 March 2021 – Final revision received 1 August 2021 – Accepted 18 August 2021) Abstract Numerous studies have revealed strong relationships between COVID-19 and inflammation. However, the imminent link between diet-related inflammation and the COVID-19 risk has not been addressed before. So, we explored the capability of the Energy-Adjusted Dietary Inflammatory Index (E-DII) to predict the inflammatory markers, incidence and severity of COVID-19. We conducted a case-control study consisting of 120 adults; they had been admitted for COVID-19 at hospital during June and July, 2020. The E-DII score was calculated based on the dietary intake, which was evaluated by a 138-item semi-quantitative food frequency questionnaire. Serum levels of inflammatory markers including the Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and White blood cells (WBCs) differential were measured. Severity of disease was assessed by chest radiology criteria. Patients with the maximum pro-inflammatory energy adjusted E-DII score had 7·26 times greater odds of developing COVID-19, as compared to those in tertiles 1 (E-DII T3 v. E-DII T1: OR = 7·26; 95 % CI 2·64 to 9·94, P < 0·001). Also, a positive association between E-DII and C-reactive protein (CRP) was observed (BE-DII = 1·37, 95 % CI 0·72, 2·02), such that with each unit increase in E-E-DII, the CRP levels were increased by 1·37 units. Furthermore, a significant association was found between E-DII and the severity of disease (BE-DII = 0·03, 95 % CI 0·01, 0·06. 0·024). Patients consuming a diet with a higher pro-inflammatory potential were at a greater risk of COVID-19 occurrence; also, the severity of disease was elevated with a high score inflammatory diet. Key words: Dietary Inflammatory Index: Severity: Inflammation: COVID-19 The outbreak of the novel coronavirus disease, also named ‘COVID-19’, has led to a devastating pandemic, threatening all humans throughout the world.(1) Currently, the number of confirmed cases is rising very quickly globally; it is an immense threat to the public health.(2) Similar to the Middle East respiratory syndrome corona virus (MERS-CoV) and severe acute respiratory syndrome corona virus (SARS-CoV), COVID-19 is characterised by the lower respiratory infection, causing acute respiratory distress syndromes.(3) Typical clinical symptoms of the..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit